Welcome to SciMar Ltd.
SciMar is a private Manitoba company founded on the discovery of the mechanism of pre-diabetic insulin resistance (AMIS Syndrome (AMISS)) and resultant pathologies including:
- Type 2 Diabetes,
- cardiovascular and renal disease, and
Our mechanistic-targeted disease management approach has led to the development of novel solutions for diagnostics, prevention, and treatment that will revolutionize this major market.